The revenue cycle management company posted $29.1 million in operating income for the period, compared to $23.9 million in the same quarter in 2023. Net loss for the second quarter was $7.6 million, compared to a $1 million net loss in the prior-year period.
Adjusted EBITDA hit $156.1 million, up from $142.9 million.
The company said the quarter reflects impacts to both revenue and costs because of recent vendor and customer outages.
“Our second-quarter results reflect the strength of R1s technology platform, our focus on delivering excellent customer results, and our ability to execute on our growth strategy while navigating industry and customer specific events,” CEO Lee Rivas said. “R1 remains committed to executing against our technology roadmap while leveraging our global scale to drive increased value for our customers and partners.”
Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice plan to acquire R1 RCM in a deal valued at $8.9 billion this year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
